Health
Researchers create AI system that matches tumors to best drug combinations – News-Medical.net
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
That’s because right now we can’t match the right combination of drugs to the right patients in a smart way. And especially for cancer, where we can’t always predict which drugs will work best given the unique, complex inner workings of a person’s tumor cells.”
Trey Ideker, PhD, Professor, School of Medicine and Moores…
-
Noosa News20 hours agoCrucial step in Sea World helicopter crash investigation set
-
General16 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Business19 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Business19 hours ago2 ASX 300 shares that look significantly undervalued